EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation

Areej El-Jawahri iD, Thomas W LeBlanc iD, Ali Kavanaugh iD, Jason Webb iD, James Fausto, Lara Traeger iD, Joseph A Greer iD, Vicki Jackson, Nora Horick iD, Dustin J Rabideau iD, Alyssa Fenech iD, Richard Newcomb iD und 7 weitere

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco-25-00378 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von Areej El-Jawahri und 18 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Palliative Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Patients undergoing hematopoietic stem cell transplantation (HSCT) and their caregivers endure immense physical and psychological symptoms, which result in quality-of-life (QOL) impairments during HSCT. METHODS We conducted a multisite randomized trial among adults undergoing autologous or allogeneic HSCT at three academic institutions. Patients were randomly assigned to an inpatient palliative care (PC) intervention or usual care. Intervention patients met with PC clinicians twice weekly during the HSCT hospitalization. Patients assigned to usual care could be referred to PC as per standard of care. We assessed QOL (patient: Functional Assessment of Cancer Therapy-Bone Marrow Transplant; caregiver: Caregiver-Oncology-QOL), depression and anxiety symptoms (Hospital-Anxiety-and-Depression-Scale), and patients' post-traumatic stress disorder (PTSD) symptoms (PTSD Checklist) at baseline, week 2, and 3 and 6 months post-HSCT. The primary end point was patients' QOL at week 2 during hospitalization when patients experience their QOL nadir. We used linear regression, adjusting for baseline scores, to evaluate the effect of the intervention on patient-reported outcomes at week 2. We used linear mixed-effect models to assess the effect of the intervention on study outcomes longitudinally. RESULTS We enrolled 68.7% (360/524) of eligible patients between October 2018 and July 2022. Compared with those receiving usual care, patients receiving the intervention reported better QOL (adjusted mean difference [B], 6.3; SE, 0.1; P < .001), lower depression (B, –1; SE, 0.4; P = .026), and fewer PTSD symptoms (B, –1.9; SE, 0.9; P = .046) at week 2. Patient-reported anxiety did not differ significantly between groups at week 2. In longitudinal analyses, patients receiving the intervention reported a steeper decline in PTSD symptoms over 6 months post-HSCT (slope difference, –0.9; SE, 0.7; P = .012). All other patient-reported outcomes did not differ longitudinally between the groups. CONCLUSION PC led to substantial improvements in patients' QOL, depression, and PTSD symptoms with sustained effects on PTSD symptoms up to 6 months post-HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPalliative CareHumansMaleFemaleMiddle AgedQuality of LifeAdultInpatientsStress Disorders, Post-TraumaticDepressionAnxietyHospitalizationAgedPatient Reported Outcome MeasuresCaregivers

Autor:innen und Institutionen

  • Massachusetts General Hospital, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC.
  • Division of Hematology/Oncology, Oregon Health and Science University, Portland, OR.
  • University of Washington, Seattle, WA.
  • Department of Psychology, University of Miami, Miami, FL.

ORCID-Profile: Areej El-Jawahri, Thomas W LeBlanc, Ali Kavanaugh, Jason Webb, Lara Traeger, Joseph A Greer, Nora Horick, Dustin J Rabideau, Alyssa Fenech, Richard Newcomb, Ella Caruso, Julia Pepper, Zachariah DeFilipp, Yi-Bin Chen, Stephanie J Lee, Jennifer S Temel

Förderung

  • NCI NIH HHS

Zitieren

APA

El-Jawahri, A., LeBlanc, T. W., Kavanaugh, A., Webb, J., Fausto, J., Traeger, L., Greer, J. A., Jackson, V., Horick, N., Rabideau, D. J., Fenech, A., Newcomb, R., Ufere, N. N., Caruso, E., Pepper, J., DeFilipp, Z., Chen, Y. B., Lee, S. J., & Temel, J. S. (2025). Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00378

Vancouver

El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb J, Fausto J, Traeger L, et al. Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation. Journal of Clinical Oncology. 2025. doi:10.1200/jco-25-00378

BibTeX
@article{ElJawahri2025,
  author = {El-Jawahri, Areej and LeBlanc, Thomas W and Kavanaugh, Ali and Webb, Jason and Fausto, James and Traeger, Lara and Greer, Joseph A and Jackson, Vicki and Horick, Nora and Rabideau, Dustin J and Fenech, Alyssa and Newcomb, Richard and Ufere, Nneka N and Caruso, Ella and Pepper, Julia and DeFilipp, Zachariah and Chen, Yi-Bin and Lee, Stephanie J and Temel, Jennifer S},
  title = {Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco-25-00378}
}
Kostenlos starten →